Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.

Vizzardi E, Bonadei I, D'Aloia A, Del Magro F, Piovanelli B, Bontempi L, Curnis A, Dei Cas L.

Minerva Med. 2011 Oct;102(5):373-9. Review.

PMID:
22193347
2.

Novel If current inhibitor ivabradine: safety considerations.

Savelieva I, Camm AJ.

Adv Cardiol. 2006;43:79-96. Review.

PMID:
16936474
3.

Rate control with ivabradine: angina pectoris and beyond.

Parakh N, Bhargava B.

Am J Cardiovasc Drugs. 2011;11(1):1-12. doi: 10.2165/11584840-000000000-00000. Review.

PMID:
21090826
4.

Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.

Borer JS, Le Heuzey JY.

Am J Ther. 2008 Sep-Oct;15(5):461-73. doi: 10.1097/MJT.0b013e3181758855. Review.

PMID:
18806523
5.

I(f) inhibition in cardiovascular diseases.

Thollon C, Vilaine JP.

Adv Pharmacol. 2010;59:53-92. doi: 10.1016/S1054-3589(10)59003-3. Review.

PMID:
20933199
6.

Selective pharmacological inhibition of the pacemaker channel isoforms (HCN1-4) as new possible therapeutical targets.

Koncz I, Szél T, Jaeger K, Baczkó I, Cerbai E, Romanelli MN, Gy Papp J, Varró A.

Curr Med Chem. 2011;18(24):3662-74.

PMID:
21774761
7.

The biological effects of ivabradine in cardiovascular disease.

Speranza L, Franceschelli S, Riccioni G.

Molecules. 2012 Apr 30;17(5):4924-35. doi: 10.3390/molecules17054924. Review.

8.

Ivabradine: beyond heart rate control.

Riccioni G, Vitulano N, D'Orazio N.

Adv Ther. 2009 Jan;26(1):12-24. doi: 10.1007/s12325-008-0130-y. Epub 2009 Jan 22. Review.

PMID:
19165437
9.

Heart rate slowing versus other pharmacological antianginal strategies.

Diaz A, Tardif JC.

Adv Cardiol. 2006;43:65-78. Review.

PMID:
16936473
10.

Heart rate lowering by inhibition of the pacemaker current: a new therapeutic perspective in cardiovascular disease.

Dilaveris P, Giannopoulos G, Synetos A, Gatzoulis K, Stefanadis C.

Cardiovasc Hematol Agents Med Chem. 2006 Oct;4(4):313-8. Review.

PMID:
17073608
11.

[Ivabradine -- a novel approach for heart rate lowering].

Er F, Hoppe UC.

Dtsch Med Wochenschr. 2005 Jun 17;130(24):1501-2. German. No abstract available.

PMID:
15942839
12.

The funny current: cellular basis for the control of heart rate.

DiFrancesco D, Borer JS.

Drugs. 2007;67 Suppl 2:15-24. Review.

PMID:
17999560
13.

Ivabradine: pharmacodynamic aspects of its clinical use.

Stieber J.

Methods Find Exp Clin Pharmacol. 2008 Oct;30(8):633-41. doi: 10.1358/mf.2008.30.8.1268816. Review.

PMID:
19088948
14.

Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.

Prasad UK, Gray D, Purcell H.

Adv Ther. 2009 Feb;26(2):127-37. doi: 10.1007/s12325-009-0005-x. Epub 2009 Mar 2. Review.

PMID:
19259630
15.

Focus on ivabradine: a new heart rate-controlling drug.

Riccioni G.

Expert Rev Cardiovasc Ther. 2009 Feb;7(2):107-13. doi: 10.1586/14779072.7.2.107. Review.

PMID:
19210206
16.
17.

[Heart rate: a risk factor or an epiphenomenon?].

Metra M, Zacà V, Lombardi C, Bugatti S, Dei Cas L.

G Ital Cardiol (Rome). 2010 Mar;11(3):209-20. Review. Italian.

PMID:
20550061
18.

Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.

Ferrari R, Ceconi C.

Expert Rev Cardiovasc Ther. 2011 Aug;9(8):959-73. doi: 10.1586/erc.11.99. Review.

PMID:
21878041
19.

Ivabradine: recent and potential applications in clinical practice.

Riccioni G.

Expert Opin Pharmacother. 2011 Feb;12(3):443-50. doi: 10.1517/14656566.2011.548321. Review.

PMID:
21254949
20.

Supplemental Content

Support Center